The recent discovery of new classes of small regulatory RNA species and the factors that control their biogenesis and function has revealed unexpected new mechanisms of gene regulation that affect normal development and, likely, cancer development. These discoveries have also led to the generation of powerful new tools for probing gene function in normal cells and in disease. This Project is focused on the investigation of the role of miRNAs in tumorigenesis and cell transformation as well as the use of RNAi to examine the function of genes in these processes. This will be investigated through a series of gene targeting experiments in the mouse directed at the mir-17approximately 92 cluster and its paralogs, which have been implicated in human tumorigenesis. These studies will also facilitate the discovery of the targets of these miRNAs. The let- 7 family of miRNAs, which have been reported to regulate Ras function, will be investigated using cell-based and in vivo methods. The role of miRNAs in tumorigenesis will be further tested by miRNA profiling experiments in a well-defined mouse model of lung cancer progression and through mutation of components of the miRNA processing machinery. Finally, this Project will seek to develop improved vectors and expression systems for constitutive and conditional shRNA expression in vivo. A specific application of this technology will be to test the function of a set of candidate tumor suppressor genes in lung cancer. Relevance statement: The elucidation of the molecular genetic events that underlie tumor development is critical for the effective treatment and prevention of cancer. This research is directed at understanding the function of a new class of regulatory molecules, termed miRNAs, in the development of cancer. The research will also lead to the development of powerful new tools to study cancer-relevant genes and pathways.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA042063-24
Application #
7907935
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
24
Fiscal Year
2009
Total Cost
$400,404
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Gao, Ang; Shrinivas, Krishna; Lepeudry, Paul et al. (2018) Evolution of weak cooperative interactions for biological specificity. Proc Natl Acad Sci U S A 115:E11053-E11060
Dubbury, Sara J; Boutz, Paul L; Sharp, Phillip A (2018) CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nature 564:141-145
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Chiu, Anthony C; Suzuki, Hiroshi I; Wu, Xuebing et al. (2018) Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP. Mol Cell 69:648-663.e7
Mori, Munemasa; Hazan, Renin; Danielian, Paul S et al. (2017) Cytoplasmic E2f4 forms organizing centres for initiation of centriole amplification during multiciliogenesis. Nat Commun 8:15857
Braun, Christian J; Stanciu, Monica; Boutz, Paul L et al. (2017) Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma. Cancer Cell 32:411-426.e11
Tammela, Tuomas; Sanchez-Rivera, Francisco J; Cetinbas, Naniye Malli et al. (2017) A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545:355-359
Sasi, Nanda Kumar; Bhutkar, Arjun; Lanning, Nathan J et al. (2017) DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways. Neoplasia 19:439-450
JnBaptiste, Courtney K; Gurtan, Allan M; Thai, Kevin K et al. (2017) Corrigendum: Dicer loss and recovery induce an oncogenic switch driven by transcriptional activation of the oncofetal Imp1-3 family. Genes Dev 31:1066

Showing the most recent 10 out of 218 publications